Adverum Biotechnologies Balance Sheet Health
Financial Health criteria checks 6/6
Adverum Biotechnologies has a total shareholder equity of $83.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $173.0M and $89.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$96.53m |
Equity | US$83.47m |
Total liabilities | US$89.54m |
Total assets | US$173.01m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0HA3's short term assets ($102.8M) exceed its short term liabilities ($24.9M).
Long Term Liabilities: 0HA3's short term assets ($102.8M) exceed its long term liabilities ($64.6M).
Debt to Equity History and Analysis
Debt Level: 0HA3 is debt free.
Reducing Debt: 0HA3 has no debt compared to 5 years ago when its debt to equity ratio was 0.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0HA3 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0HA3 has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 15.1% each year.